Series Overview:
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the extension of this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet every Thursday at 12:00pm Eastern Time and is available for on-demand viewing immediately following the live broadcast.
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/grandrounds for easy access.
Target Audience:
This program has been designed for physicians, fellows, residents, medical students, physician assistants, pharmacists, medical assistants, professional nurses, advanced practice nurses in dermatology, family medicine, internal medicine, infectious diseases, obstetrics and gynecology, pediatrics, psychiatry, and neurology.
Commercial Support Acknowledgement:
HIV Grand Rounds is supported by educational grants from Gilead, Janssen and ViiV Healthcare.
LEARNING OBJECTIVES FOR THE SERIES:
Upon completion of the educational activity, participants should be able to:
-
Apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients into care;
-
Individualize ARV therapy for the treatment-naïve and treatment-experienced patients;
-
Manage the aging patient with HIV infection, including issues associated with cardiovascular and bone disease.
LEARNING OBJECTIVES FOR THE SEssion:
Upon completion of the educational activity, participants should be able to:
-
Describe implications of timing of antiretroviral exposure on the risk of birth defects
-
Discuss the management of women living with HIV during pregnancy
-
Explain individual differences in infant prophylaxis and breastfeeding recommendations
PROGRAM FACULTY:
|
William R. Short, MD, MPH
Associate Professor of Medicine
Associate Professor of Obstetrics and Gynecology
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
|
| |
Elizabeth Lowenthal, MD, MSCE, FAAP, AAHIVS
Assistant Professor of Pediatrics and Epidemiology
Perelman School of Medicines at the University of Pennsylvania
Philadelphia, Pennsylvania
|
| |
Florence Momplaisir, MD
Assistant Professor of Medicine
Division of Infectious Diseases & HIV Medicine
Drexel College of Medicine
Philadelphia, Pennsylvania
|
| |
Richard M. Rutstein, MD
Professor of Pediatrics
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
|
Accreditation Statement:
In support of improving patient
care, Penn Medicine is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy
Education (ACPE), and the American Nurses Credentialing Center (ANCC), to
provide continuing education for the healthcare team.
Designation of Credit:
Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1 Category 1 credits for completing this activity.
TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures:
It is policy at the Perelman School of Medicine at the University of Pennsylvania and ViralEd, Inc. for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania (Rodman Campbell, Mila Kostic, Michael Schoen, PhD and Mindy Pollock Troy), our educational partner ViralEd, Inc. (Richard Gordon, Brian Boyle, MD, JD), and the peer reviewer, Zalman Agus, MD, Associate Dean for Continuing Medical Education, have reported that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
|
Brian Boyle, MD
|
Rick Gordon
|
Mila Kostic, CHCP, FACEHP |
Oliver Fultz |
|
| Richard Rutstein, MD |
Florence Momplaisir, MD
|
|
|
|
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
Faculty/Planning Committee Disclosures:
|
Ian Frank, MD
|
Gilead, GlaxoSmithKline
|
Advisor or Review Panel Member
|
| |
Johnson & Johnson
|
Grant/Research Support Recipient
|
William Short, MD
|
ViiV, Gilead
|
Consultant
|
Elizabeth Lowenthal, MD
|
Otsuka
|
Spouse is employee,Otsuka does not have any drugs relevent to this presentation |
Discussion of Investigational and/or Off-label Use of commercial products and devices:
The Perelman School of Medicine at the University of Pennsylvania requires all faculty to disclose any discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
Faculty members will disclose to participants any discussions of off-label and/or investigational uses of pharmaceutical products within their presentations.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
register/View:
